Woodline Partners’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-48,467
Closed -$954K 606
2024
Q2
$954K Sell
48,467
-291
-0.6% -$5.73K 0.01% 462
2024
Q1
$1.25M Buy
48,758
+23,751
+95% +$608K 0.01% 446
2023
Q4
$690K Sell
25,007
-111,430
-82% -$3.08M 0.01% 411
2023
Q3
$8.3M Buy
136,437
+97,292
+249% +$5.92M 0.1% 245
2023
Q2
$2.58M Sell
39,145
-251
-0.6% -$16.5K 0.03% 394
2023
Q1
$2.51M Sell
39,396
-25,139
-39% -$1.6M 0.03% 393
2022
Q4
$8.93M Buy
64,535
+7,607
+13% +$1.05M 0.12% 230
2022
Q3
$7.21M Buy
+56,928
New +$7.21M 0.1% 239
2021
Q3
Sell
-7,947
Closed -$3.29M 683
2021
Q2
$3.29M Buy
7,947
+5,284
+198% +$2.19M 0.06% 283
2021
Q1
$1.04M Buy
+2,663
New +$1.04M 0.02% 361